QDEL vs SDGR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
QuidelOrtho exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a technical trend score of 0/100. Despite appearing 'cheap' on a Price-to-Book (0.45) and Price-to-Sales (0.32) basis, the company suffers from negative profit margins (-41.45%) and a catastrophic 5-year price decline of 89.6%. The disconnect between the bullish analyst target ($30.83) and the deteriorating fundamental health suggests a classic value trap. The lack of revenue growth (2.2%) and negative ROE (-46.15%) further undermine any recovery thesis.
SDGR exhibits significant financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' category. Despite a strong liquidity position (Current Ratio 2.75) and low leverage (Debt/Equity 0.30), the company suffers from persistent negative profitability and stagnant revenue growth (-1.20% YoY). The severe long-term price erosion (-83% over 5 years) and bearish insider activity contrast sharply with the optimistic analyst 'strong_buy' consensus, suggesting a disconnect between fundamental performance and market expectations.
Compare Another Pair
Related Comparisons
QDEL vs SDGR: Head-to-Head Comparison
This page compares QuidelOrtho Corporation (QDEL) and Schrödinger, Inc. (SDGR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.